BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

661 related articles for article (PubMed ID: 36868394)

  • 1. Towards artificial intelligence to multi-omics characterization of tumor heterogeneity in esophageal cancer.
    Li J; Li L; You P; Wei Y; Xu B
    Semin Cancer Biol; 2023 Jun; 91():35-49. PubMed ID: 36868394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Artificial intelligence-based multi-omics analysis fuels cancer precision medicine.
    He X; Liu X; Zuo F; Shi H; Jing J
    Semin Cancer Biol; 2023 Jan; 88():187-200. PubMed ID: 36596352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics, artificial intelligence, and precision medicine in perinatology.
    Pammi M; Aghaeepour N; Neu J
    Pediatr Res; 2023 Jan; 93(2):308-315. PubMed ID: 35804156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Towards multi-omics characterization of tumor heterogeneity: a comprehensive review of statistical and machine learning approaches.
    Lee D; Park Y; Kim S
    Brief Bioinform; 2021 May; 22(3):. PubMed ID: 34020548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective.
    Yang Z; Guan F; Bronk L; Zhao L
    Pharmacol Ther; 2024 Feb; 254():108591. PubMed ID: 38286161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lung cancer multi-omics digital human avatars for integrating precision medicine into clinical practice: the LANTERN study.
    Lococo F; Boldrini L; Diepriye CD; Evangelista J; Nero C; Flamini S; Minucci A; De Paolis E; Vita E; Cesario A; Annunziata S; Calcagni ML; Chiappetta M; Cancellieri A; Larici AR; Cicchetti G; Troost EGC; Ádány R; Farré N; Öztürk E; Van Doorne D; Leoncini F; Urbani A; Trisolini R; Bria E; Giordano A; Rindi G; Sala E; Tortora G; Valentini V; Boccia S; Margaritora S; Scambia G
    BMC Cancer; 2023 Jun; 23(1):540. PubMed ID: 37312079
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Single-cell multi-omics sequencing and its application in tumor heterogeneity.
    Sun Y; Liu Z; Fu Y; Yang Y; Lu J; Pan M; Wen T; Xie X; Bai Y; Ge Q
    Brief Funct Genomics; 2023 Jul; 22(4):313-328. PubMed ID: 37078714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrating Multi-Omics Data With EHR for Precision Medicine Using Advanced Artificial Intelligence.
    Tong L; Shi W; Isgut M; Zhong Y; Lais P; Gloster L; Sun J; Swain A; Giuste F; Wang MD
    IEEE Rev Biomed Eng; 2024; 17():80-97. PubMed ID: 37824325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
    Ahmed Z
    Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Artificial Intelligence for Precision Oncology.
    Bhalla S; Laganà A
    Adv Exp Med Biol; 2022; 1361():249-268. PubMed ID: 35230693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Omics-Based Investigations of Breast Cancer.
    Neagu AN; Whitham D; Bruno P; Morrissiey H; Darie CA; Darie CC
    Molecules; 2023 Jun; 28(12):. PubMed ID: 37375323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multi-Omics Model Applied to Cancer Genetics.
    Pettini F; Visibelli A; Cicaloni V; Iovinelli D; Spiga O
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
    Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-omics analysis: Paving the path toward achieving precision medicine in cancer treatment and immuno-oncology.
    Raufaste-Cazavieille V; Santiago R; Droit A
    Front Mol Biosci; 2022; 9():962743. PubMed ID: 36304921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Machine learning meets omics: applications and perspectives.
    Li R; Li L; Xu Y; Yang J
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34791021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Artificial intelligence (AI) and machine learning (ML) in precision oncology: a review on enhancing discoverability through multiomics integration.
    Wei L; Niraula D; Gates EDH; Fu J; Luo Y; Nyflot MJ; Bowen SR; El Naqa IM; Cui S
    Br J Radiol; 2023 Oct; 96(1150):20230211. PubMed ID: 37660402
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applying Machine Learning for Integration of Multi-Modal Genomics Data and Imaging Data to Quantify Heterogeneity in Tumour Tissues.
    Tan X; Su AT; Hajiabadi H; Tran M; Nguyen Q
    Methods Mol Biol; 2021; 2190():209-228. PubMed ID: 32804368
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A journey from omics to clinicomics in solid cancers: Success stories and challenges.
    Mehrotra S; Sharma S; Pandey RK
    Adv Protein Chem Struct Biol; 2024; 139():89-139. PubMed ID: 38448145
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tracking the evolution of esophageal squamous cell carcinoma under dynamic immune selection by multi-omics sequencing.
    Cui S; McGranahan N; Gao J; Chen P; Jiang W; Yang L; Ma L; Liao J; Xie T; Xie C; Enver T; Wu S
    Nat Commun; 2023 Feb; 14(1):892. PubMed ID: 36807354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.